Correlation Between Neuronetics and Perspective Therapeutics

Can any of the company-specific risk be diversified away by investing in both Neuronetics and Perspective Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuronetics and Perspective Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuronetics and Perspective Therapeutics, you can compare the effects of market volatilities on Neuronetics and Perspective Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuronetics with a short position of Perspective Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuronetics and Perspective Therapeutics.

Diversification Opportunities for Neuronetics and Perspective Therapeutics

0.37

Correlation Coefficient

Neuronetics  Perspective Therapeutics

Weak diversification

The 3 months correlation between Neuronetics and Perspective is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Neuronetics and Perspective Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Perspective Therapeutics and Neuronetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuronetics are associated (or correlated) with Perspective Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Perspective Therapeutics has no effect on the direction of Neuronetics i.e., Neuronetics and Perspective Therapeutics go up and down completely randomly.

Pair Corralation between Neuronetics and Perspective Therapeutics

Given the investment horizon of 90 days Neuronetics is expected to generate 0.68 times more return on investment than Perspective Therapeutics. However, Neuronetics is 1.47 times less risky than Perspective Therapeutics. It trades about -0.13 of its potential returns per unit of risk. Perspective Therapeutics is currently generating about -0.1 per unit of risk. If you would invest  334.00  in Neuronetics on August 15, 2025 and sell it today you would lose (118.00) from holding Neuronetics or give up 35.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Neuronetics  vs.  Perspective Therapeutics

Neuronetics

Risk-Adjusted Performance

Weakest

Over the last 90 days Neuronetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in December 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Perspective Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Perspective Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Neuronetics and Perspective Therapeutics

The main advantage of trading using opposite Neuronetics and Perspective Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuronetics position performs unexpectedly, Perspective Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Perspective Therapeutics will offset losses from the drop in Perspective Therapeutics' long position.

The idea behind Neuronetics and Perspective Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.